News › GlobeNewswire Inc.

Vivos Inc Summarizes Progress in its Animal Therapy Division

GlobeNewswire Inc. • Dec 22, 2025 12:56pm (New York) •By Not Specified

Vivos Inc Summarizes Progress in its Animal Therapy Division

Vivos Inc.'s IsoPet division achieved 1,200% year-over-year growth in administered therapies from 2024 to 2025, with over 100 treatments safely performed across various animal species. The company expanded its certified clinic network to 17 locations by year-end 2025, including new certifications at Sun City Veterinary Surgery Center in Texas and University of Florida Small Animal Hospital. The division plans to implement profitability-focused initiatives in Q1 2026 while continuing clinic expansion, with multiple clinical publications anticipated to support veterinary adoption.

← Back to news Read Original Article

Insights

SFTBY neutral

Sold a minimal stake (0.12% of market cap) with minimal market impact

RDGL positive

The company demonstrated exceptional growth metrics (1,200% YoY increase), expanded its certified clinic network significantly, completed case study therapies, and secured strategic partnerships. Plans for profitability initiatives and anticipated clinical publications in 2026 further support positive momentum in the IsoPet division.

Keywords

#IsoPet therapy #veterinary oncology #radionuclide therapy #clinic expansion #clinical studies #equine treatment #companion animal care #cancer treatment

Tickers

RDGL

← Prev: SFM INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of a Lawsuit accusing Officers of Sprouts Farmers Market of Securities Fraud Violations

Next: Deadline Alert: Synopsys, Inc. (SNPS) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit →